We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Identifies Hidden Heart Valve Defects from Patient’s ECG

By HospiMedica International staff writers
Posted on 08 Aug 2025

Heart valve diseases, affecting over 41 million people globally, can lead to heart failure, hospitalization, and even death. More...

Early diagnosis is critical, yet symptoms like shortness of breath or dizziness are often misattributed, and some patients show no signs until the disease is advanced. Subtle changes in heart function, especially in its electrical activity, often go undetected until it’s too late. Researchers have now created an artificial intelligence (AI) tool to identify risk much earlier, using just a standard electrocardiogram (ECG).

Developed by researchers at Imperial College London (London, UK), the AI model uses a patient’s ECG to predict the risk of developing regurgitant valvular heart diseases. These conditions, which affect the mitral, tricuspid, or aortic valves, involve blood leaking backwards through the heart. The AI detects early structural changes in the heart that are not apparent to doctors, making it possible to flag high-risk patients earlier than ever before physical symptoms or damage appear.

The research team trained the algorithm on nearly one million ECG and echocardiogram records from over 400,000 patients in China. To ensure accuracy across populations, the tool was then validated on over 34,000 patients in the US, showing that it works well across ethnically diverse populations and healthcare systems. The study, published in The European Heart Journal, shows that the AI model successfully predicted valve disease risk 69–79% of the time, showing reliable performance across diverse ethnic groups and healthcare settings.

Additionally, high-risk patients identified by the AI were up to 10 times more likely to develop valve leakage, offering a critical window for prevention. This technology could revolutionize care by identifying patients in need of monitoring or early intervention, long before heart valve disease causes harm. The research follows on from the team’s development of the related AI-ECG risk estimation model, known as AIRE, which can predict patients’ risk of developing and worsening disease from an ECG.

“Our work is harnessing AI to detect subtle changes at the earliest stage from a simple and common test, and we think this could be really transformative for doctors and patients,” said Dr. Arunashis Sau, one of the study leads. "Rather than waiting for symptoms or relying only on expensive and time-consuming imaging tests, we could use AI-enhanced ECGs to spot those most at risk earlier than ever before."


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.